August 16, 2016
Japan Tobacco said on August 15 that it has filed a new drug application in Japan for Gilead Sciences’ fixed-dose combination of emtricitabine and tenofovir alafenamide (TAF), known as Descovy overseas, for the treatment of HIV infection. Once approved, the...read more